Stay updated on Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial

Sign up to get notified when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Website version updated from v3.4.3 to v3.5.0. No study content or user-facing details were altered.
    Difference
    0.1%
    Check dated 2026-03-20T19:55:53.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. This appears to be a minor site update with no changes to study content.
    Difference
    0.1%
    Check dated 2026-03-06T18:11:18.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated: v3.4.2 added; v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:32:34.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no substantive changes to study details or page interactions are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:12:00.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. This appears to be a backend/versioning update that does not alter study information or navigation.
    Difference
    0.1%
    Check dated 2026-01-15T04:28:03.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Locations were updated: New Hampshire, New York, Tennessee, Texas, and Victoria were added and prior location entries removed; the HHS Vulnerability Disclosure link was removed (Revision: v3.3.3).
    Difference
    0.7%
    Check dated 2025-12-24T13:52:30.000Z thumbnail image

Stay in the know with updates to Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.